These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 16640109)
1. Are cross-species measures of sensorimotor gating useful for the discovery of procognitive cotreatments for schizophrenia? Geyer MA Dialogues Clin Neurosci; 2006; 8(1):9-16. PubMed ID: 16640109 [TBL] [Abstract][Full Text] [Related]
2. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps? Geyer MA Neurotox Res; 2006 Dec; 10(3-4):211-20. PubMed ID: 17197371 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Geyer MA; Krebs-Thomson K; Braff DL; Swerdlow NR Psychopharmacology (Berl); 2001 Jul; 156(2-3):117-54. PubMed ID: 11549216 [TBL] [Abstract][Full Text] [Related]
4. Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Linn GS; Negi SS; Gerum SV; Javitt DC Psychopharmacology (Berl); 2003 Sep; 169(3-4):234-9. PubMed ID: 12845408 [TBL] [Abstract][Full Text] [Related]
5. Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia. Oranje B; Van Oel CJ; Gispen-De Wied CC; Verbaten MN; Kahn RS J Clin Psychopharmacol; 2002 Aug; 22(4):359-65. PubMed ID: 12172334 [TBL] [Abstract][Full Text] [Related]
6. (+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics. Cilia J; Hatcher P; Reavill C; Jones DN J Psychopharmacol; 2007 May; 21(3):302-11. PubMed ID: 17591657 [TBL] [Abstract][Full Text] [Related]
7. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Swerdlow NR; Braff DL; Taaid N; Geyer MA Arch Gen Psychiatry; 1994 Feb; 51(2):139-54. PubMed ID: 8297213 [TBL] [Abstract][Full Text] [Related]
8. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109 [TBL] [Abstract][Full Text] [Related]
9. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Kumari V; Antonova E; Geyer MA; Ffytche D; Williams SC; Sharma T Int J Neuropsychopharmacol; 2007 Aug; 10(4):463-77. PubMed ID: 16923324 [TBL] [Abstract][Full Text] [Related]
10. Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine. Quednow BB; Wagner M; Westheide J; Beckmann K; Bliesener N; Maier W; Kühn KU Biol Psychiatry; 2006 Mar; 59(6):536-45. PubMed ID: 16139819 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia]. Suemaru K; Kohnomi S; Umeda K; Araki H Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):121-6. PubMed ID: 18646597 [TBL] [Abstract][Full Text] [Related]
12. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Johansson C; Jackson DM; Zhang J; Svensson L Pharmacol Biochem Behav; 1995 Dec; 52(4):649-54. PubMed ID: 8587900 [TBL] [Abstract][Full Text] [Related]
13. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Swerdlow NR; Geyer MA Schizophr Bull; 1998; 24(2):285-301. PubMed ID: 9613626 [TBL] [Abstract][Full Text] [Related]
14. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects. Feifel D; Melendez G; Shilling PD Neuropsychopharmacology; 2004 Apr; 29(4):731-8. PubMed ID: 14760394 [TBL] [Abstract][Full Text] [Related]
15. Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics. Kumari V; Soni W; Sharma T Schizophr Res; 2002 May; 55(1-2):139-46. PubMed ID: 11955973 [TBL] [Abstract][Full Text] [Related]
16. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616 [TBL] [Abstract][Full Text] [Related]
17. Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density. Wolf R; Paelchen K; Matzke K; Dobrowolny H; Bogerts B; Schwegler H Psychopharmacology (Berl); 2007 Sep; 194(1):93-102. PubMed ID: 17541558 [TBL] [Abstract][Full Text] [Related]
18. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Swerdlow NR; Geyer MA Pharmacol Biochem Behav; 1993 Mar; 44(3):741-4. PubMed ID: 8451276 [TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats. Zangrando J; Carvalheira R; Labbate G; Medeiros P; Longo BM; Melo-Thomas L; Silva RC Behav Brain Res; 2013 Nov; 257():77-82. PubMed ID: 24045065 [TBL] [Abstract][Full Text] [Related]
20. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients. Swerdlow NR; Bhakta SG; Talledo JA; Franz DM; Hughes EL; Rana BK; Light GA Neuropsychopharmacology; 2018 Mar; 43(4):708-717. PubMed ID: 29154367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]